Hims Hers Health Inc (HIMS)
Return on equity (ROE)
| Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 101,258 | 18,103 | -2,351 | -23,546 | -35,720 | -46,993 | -59,515 | -65,700 | -85,932 | -83,033 | -72,507 | -107,659 | -81,727 | -71,657 | -63,485 | -18,114 | -12,157 | -5,850 | -4,886 | |
| Total stockholders’ equity | US$ in thousands | 440,051 | 361,966 | 344,482 | 344,029 | 328,562 | 320,071 | 312,745 | 311,741 | 310,946 | 319,059 | 327,715 | 334,619 | 355,153 | 293,054 | 292,466 | -146,874 | -143,341 | -138,949 | -139,953 | -139,793 |
| ROE | 23.01% | 5.00% | -0.68% | -6.84% | -10.87% | -14.68% | -19.03% | -21.08% | -27.64% | -26.02% | -22.13% | -32.17% | -23.01% | -24.45% | -21.71% | — | — | — | — |
September 30, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $101,258K ÷ $440,051K
= 23.01%
The return on equity (ROE) of Hims Hers Health Inc has shown fluctuations over the past several quarters. The ROE for September 2024 stood at 23.01%, a significant increase compared to the previous quarter's ROE of 5.00% in June 2024. This improvement indicates that the company generated a higher level of net income relative to its shareholders' equity.
However, it is important to note that prior to this increase, the company's ROE experienced negative values for consecutive quarters, reaching a low of -27.64% in September 2022. A negative ROE suggests that the company's net income was not sufficient to cover its shareholders' equity, indicating potential financial challenges.
The recent positive trend in ROE may indicate improved profitability and efficiency in the company's operations. Investors and stakeholders should monitor future ROE figures to assess the sustainability of this positive performance and to gain insights into the company's financial health and management effectiveness.